Therapeutic Asset Ratings
462 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti Alpp Car-T Cells Treatment
Neoplasm
TCRCure Biopharma Ltd.
Early P1
C
(33)
azd9592
Neoplasm
Presage Biosciences
Early P1
C
(33)
ben101
Neoplasm
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early P1
C
(33)
Enhanced Alpp Car-T Treatment
Neoplasm
TCRCure Biopharma Ltd.
Early P1
C
(33)
Fast Car T Cells
Neoplasm
Shanghai Cell Therapy Group Co.,Ltd
Early P1
C
(33)
gt316
Neoplasm
Grit Biotechnology
Early P1
C
(33)
ibi3026
Neoplasm
Innovent Biologics Technology Limited (Shanghai R&D Center)
Early P1
C
(33)
ksh01
Neoplasm
TCRx Therapeutics Co.Ltd
Early P1
C
(33)
lm103
Neoplasm
Suzhou BlueHorse Therapeutics Co., Ltd.
Early P1
C
(33)
lm303
Neoplasm
Suzhou BlueHorse Therapeutics Co., Ltd.
Early P1
C
(33)
rd133
Neoplasm
The First Affiliated Hospital with Nanjing Medical University
Early P1
C
(33)
rd14-01 cell
Neoplasm
Shen Lin
Early P1
C
(33)
Rilvegostomig
Neoplasm
Presage Biosciences
Early P1
C
(33)
ROCK2 INHIBITOR KD025
Neoplasm
jianming xu
Early P1
C
(33)
Sabestomig
Neoplasm
Presage Biosciences
Early P1
C
(33)
Volrustomig
Neoplasm
Presage Biosciences
Early P1
C
(33)
αpd1/ctla4-msln-car t cells
Neoplasm
Shanghai Cell Therapy Group Co.,Ltd
Early P1
C
(33)
Zandelisib
Neoplasm
Salubris Biotherapeutics Inc
P1/2
D
(30)
18F-WL12
Neoplasm
Peking University Cancer Hospital & Institute
N/A
D
(26)
[68Ga]Ga-THP-PDL1-3
Neoplasm
Hua Zhu
N/A
D
(26)
68Ga-WL12
Neoplasm
Peking University Cancer Hospital & Institute
N/A
D
(26)
CETIRIZINE
Neoplasm
Erasmus Medical Center
D
(26)
CLEMASTIN
Neoplasm
Erasmus Medical Center
D
(26)
FOLactis
Neoplasm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
N/A
D
(26)
her2-e-cart cells
Neoplasm
su haichuan
N/A
D
(26)
Showing 426 to 450 of 462 assets
Previous
Page 18 of 19
Next
